59 GM-CSF does not reduce the incidence of febrile...

59 GM-CSF does not reduce the incidence of febrile neutropenia during combination chemotherapy for small cell lung cancer (SCLC). A west of Scotland lung cancer group trial

Milroy, R., Dorward, A., Bicknell, S., Vernon, D., Cameron, C., McGregor, K., Steward, W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(97)89338-5
Date:
August, 1997
File:
PDF, 152 KB
english, 1997
Conversion to is in progress
Conversion to is failed